ASCO® GI 2024 Insights: "NRG-GI005 (COBRA) Study - ctDNA as a Predictive Biomarker in Adjuvant Chemo in Patients With Stage II Colon Cancer" | VuMedi

Find latest Colon Cancer videos · 300+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Insights: "NRG-GI005 (COBRA) Study - ctDNA as a Predictive Biomarker in Adjuvant Chemo in Patients With Stage II Colon Cancer"

By Insights from 2024 ASCO® GI Annual Meeting FEATURING Van Morris

By Insights from 2024 ASCO® GI Annual Meeting FEATURING Van Morris

308 views

February 1, 2024

Comments 0

Login to view comments. Click here to Login